A Study of Amicidin-β Topical Solution for Patients With Surgical or Traumatic Wound Infections (NCT07379684)
A Phase 1 Study to Assess Safety and Tolerability of Amicidin-β Topical Solution in Adult Patients Undergoing Interventional Management of a Surgical or Traumatic Wound Infection
🩺 Plain-English Summary (8th-Grade Level)
The goal of this Phase 1 clinical trial is to learn about the safety profile of Amicidin-β topical solution applied directly into infected surgical or traumatic wounds during a surgical procedure. The main questions it aims to answer are: 1. Is Amicidin-β topical solution safe to test in larger clinical trials? 2. Is Amicidin-β topical solution absorbed into the bloodstream from local wound application? 3. Is Amicidin-β topical solution easy for the surgeon to use? Participants will receive either standard of care alone, or standard of care with intrawound Amicidin-β topical solution for the management of their wound infection. Researchers will compare these two groups (standard of care alone to standard of care with Amicidin-β topical solution) to see if there are any study drug-related adverse effects.
Who can join: Review the eligibility criteria below.
Location: Lundquist Institute — Torrance, California
Age range: 18 Years to 79 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (5 Sites)
- Lundquist Institute — Torrance, California
- Snake River Research, PLLC — Idaho Falls, Idaho
- LifeBridge Health — Baltimore, Maryland
- Washington University in St. Louis — St Louis, Missouri
- The Ohio State University — Columbus, Ohio
📞 Contact the Study Coordinator
Phone: (323) 717-0302
Email: dgowenhuang@macrobiologics.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Surgical Wound Infection
- Sucrose as a Standard in Cesarean Section Surgical Wound Healing to Reduce Hospital Time — Tegucigalpa, Francisco Morazán Department
- The Effect of Bacterial Decolonization Before Skin Cancer Surgery on Infection Rate of Lower Extremity Wounds Left Open to Heal — Marlton, New Jersey
Explore by condition: All Surgical Wound Infection clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.